Share Name Share Symbol Market Type Share ISIN Share Description
Mercia Technolgies PLC LSE:MERC London Ordinary Share GB00BSL71W47 ORD 0.001P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 36.70p 36.00p 37.40p 36.70p 36.70p 36.70p 9,030 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 6.7 1.0 0.5 78.1 110.32

Mercia Technolgies Share Discussion Threads

Showing 201 to 225 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
31/1/2018
19:20
They told me current NAV was 56p but this was in the public sphere. I am always cautious on NAVs for companies holding unquoted securities as the valuation methods are opaque. How do they treat intangibles? But they do hold a lot of cash as well, both on the balance sheet (for direct investments) and in the managed funds. I have failed to get to grips with this NAV calculation today so am not considering buying until I do. Perhaps the fund management operation might be worth £7mn? I also noticed that Concepta, one of the (I think) two listed companies held as assets in the balance sheet, has not been stellar since listing though is just above the price of the December fund-raising in which Mercia topped up their holding. They own 18% but this is only one of roughly 20 direct investments and should be worth about £1.8mn of the pot which they valued at £65mn at end September - this is obviously bigger now on their valuation. What I did like about the company was the aggregate growth of the managed funds (now £350mn after the $100mn investment from the two Northern Powerhouse Funds). Some really excellent institutions are in the fact that this increase guarantees higher management fee revenues the apparent high quality of the men who were at the presentation It feels like a safe l-t investment though clearly unquoted fund holdings will tend to do badly in a major market downturn or recession, will they not? Perhaps one for the grandkids? Any comments, obvious errors here?
srichardson8
31/1/2018
10:14
"Set in the context that Mercia operates a long-term investment philosophy, by combining third-party managed funds with selective scale-up capital directly from its balance sheet, all parts of the Group are in a growth phase and so it is pleasing to see an increase in post-tax profits to £1.4million and Net Asset Value ("NAV") per share increase to 41.1pence. Spot on. I don't see how they can make that statement. You can only reiterate information that is not price sensitive ie. already reported to the market. That seems like an error to me.
redartbmud
31/1/2018
09:55
MERC were at the Growth and Innovation meeting yesterday and flagged that they had a current NAV of 76p. He said that was in the public domain, but all I see in the half year results is "NAV per share grew 7.9% to 41.1 pence (H1 2016: 38.1 pence)." Not sure what to believe; as the results are from Dec the 76p seems unlikely....
fredfishcake
14/1/2018
09:42
I hold MERC and PHD. Take a quick look at PHD thread. Sci Warehouse looks very tempting as PHD target. Would be no surprise to see some activity there, MERC hold 62%. Sci Warehouse look a little out of place now in the MERC portfolio, at least to me, and hard to see where they go from here as they don't have big scale in their rapidly consolidating market place. Offloading to PHD is not out of the question and needn't be bad for all concerned. Both in Leeds. PHD scaling up, profitable, and looking for around £20M extra acquired revenue by 2021. Sci Warehouse looks tasty. See Progressive Equity report on PHD to get the idea. Current revenue about £68M for PHD, Sci Warehose probably £4M - £5M and although they can grow its only a matter of time before they are taken out or wither. Just imho. Next market downturn might see some activity here.
p1nkfish
10/1/2018
15:25
The buying today seems to support my last post. 50p looks imminent...
turbocharge
09/1/2018
13:41
Going by the chart history, looks like there is more to come
turbocharge
09/1/2018
12:08
Nice move up today I see :-)
cheshire man
08/1/2018
18:12
Up around 30% in the last two months. Techinvest says "continue to buy"
aishah
05/1/2018
13:29
Thanks for that purble,,,,some interest to start the year :-)
cheshire man
05/1/2018
07:43
Mercia Technologies (MERC) 36.25p Technology businesses developer and fund manager Mercia Technologies (MERC) has built up an attractive portfolio of technology companies and has plenty of cash in the bank, thanks to the dilutive £40 million fundraising at the beginning of 2017. That cash is being invested and it enables Mercia to take larger stakes in its investee companies. Mercia has invested £3.5 million in Manchester-based website traffic software developer Intechnica. The TrafficDefender software can remove unwanted traffic from bots and Mercia had previously made a small initial investment. A further £2.5 million has been put in drug delivery patch developer Medherant. Mercia has secured a partnership with Edinburgh University and this should provide further life sciences opportunities. Mercia's investment focus is on software, digital, electronics/engineering and life sciences and 99% of the value of the investment portfolio is accounted for by 18 investments. Additional fund management mandates will increase income so that it will cover a majority of group costs. This means that more of the cash raised can be invested rather than used to cover operating costs. The NAV was 41.1p a share at the end of September 2017, including cash of 16p a share, although some of this has since been invested. The discount to NAV is 12%. Rivals, such as IP Group and Frontier IP, are trading at a premium to assets. This is a good time to buy the shares. Existing investments are maturing and cash still has to be put to work
purple11
02/1/2018
11:49
Five AIM share tips for 2018 - MERC one of them: hxxp://www.i i i.co.uk/articles/470969/five-aim-share-tips-2018
aishah
02/1/2018
11:00
Has there been a recent broker upgrade? It looks that way on Stockopedia.
mctmct
19/12/2017
22:19
Alternatively look at the CAGR on the share price needed over 2 years for them to get a pay out. I think they will reach for it and PI's likely to benefit.
p1nkfish
18/12/2017
19:54
Forgive me if you know all this. I was warming to Mercia at this price, until this RNS. In chartist speak we hav3 a bowl forming. But I really really don’t like the bit about, if at first the options don’t vest because we mucked up, keep the options....etc. I found Mercia from reading some EIS promotional material...opportunity to invest in selected companies etc. It became clear to me that Mercia invest ahead and alongside and collect management fees come what may. I would rather back the field and collect fees so Mercia rather than the investee Cos caught my interest. Not now.
steve3sandal
18/12/2017
17:18
I have been ing over a period as the portfolio looks very useful to me and Merc relatively unloved.
p1nkfish
18/12/2017
15:15
18 December 2017 Amendment to Share Options At the time of the Company's IPO on 18 December 2014 ("Admission") options (the "Options") over 1,000,000 new Ordinary shares with a nominal value of 0.001p pence each in the capital of the Company ("Ordinary Shares") were awarded to each of Dr. Mark Payton, Chief Executive Officer and Martin Glanfield, Chief Financial Officer, both directors of Mercia (together the "Executive Directors"). The Options were awarded pursuant to the 2014 Mercia Company Share Option Plan ("Mercia CSOP"). The Options were subject to a performance condition which would have been satisfied if the total shareholder return (being the increase in the price of an Ordinary Share from a 50.0 pence base value plus any dividend yield) from Admission to the third anniversary of Admission was not less than 9.55 pence (being 6% compound per annum). The exercise price (being the price per share payable on the exercise of such options) would therefore have been 59.55 pence had the performance condition been satisfied. The performance condition has not been satisfied on the third anniversary of Admission. However, having considered the matter at length and pursuant to the rules of the Mercia CSOP, the Company's Remuneration Committee has elected to vary the vesting period in which the performance condition of the Options has to be satisfied. Accordingly, the Options will now vest on the fifth anniversary of Admission if the total shareholder return from Admission to the fifth anniversary of Admission is not less than 9.55 pence. If the performance condition is satisfied on the fifth anniversary of Admission the exercise price will be 59.55 pence. The Remuneration Committee considers that this is the most appropriate way of continuing to align the interests of the Executive Directors with the shareholders of the Company, whilst continuing to provide a strong incentive, thereby facilitating the retention of high calibre individuals.
turbocharge
12/12/2017
09:43
Decent buying going on here,,,,,happy to tuck away and see where it takes me :-)
cheshire man
12/12/2017
08:16
Http://www.thisismoney.co.uk/money/investing/article-5164389/Midas-update-Patience-pay-tech-entrepreneurs.html#ixzz5124v2lx8
cheshire man
07/12/2017
01:37
Mercia Technologies Advice Buy: Why Long-term potential for those with patience and a healthy risk appetite. https://www.thetimes.co.uk/edition/business/floats-add-buoyancy-in-choppy-water-twcldxq2m
masurenguy
06/12/2017
08:59
Woodford may not agree, but I just think this is such a better bet than ALM, being on a reasonable discount to NAV and with a proven track record (for the managers at least).
spectoacc
27/11/2017
08:17
Interesting recent news from a Mercia portfolio company, MIP Diagnostics- 21st November 2017 Breakthrough Discovery In Diagnostic Tools That Can Replace Antibodies In a newly released article “A comparison of the performance of molecularly imprinted polymer nanoparticles for small molecule targets and antibodies in the ELISA format” the researchers successfully demonstrated that polymer nanoparticles produced by the molecular imprinting technique (MIP nanoparticles) can bind to the target molecule with the same or higher affinity and specificity than widely used commercially available antibodies and against challenging targets. Additionally, their ease of manufacture, short lead time, high affinity and the lack of requirement for cold chain logistics make them an attractive alternative to traditional antibodies for use in immunoassays. The robust nature of MIP nanoparticles makes them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. They can withstand harsh environments, such as extremes of pH and temperature, seawater and can even function in organic solvents. Full article - https://tinyurl.com/molecular-imprinting
wan
14/11/2017
07:40
Update reads well: https://www.investegate.co.uk/mercia-technologies--merc-/rns/life-sciences---biosciences-sector-update/201711140700064150W/ "The Life Sciences & Biosciences portfolio is progressing at an impressive rate as a result of close collaboration with our 19 university partners and a highly experienced Investment Team, both of which provide an important source of highly disruptive deal flow opportunities. All five of the existing sector portfolio have come through our managed funds, with four of these via our university partnerships and one through the Investment Team's personal networks. Securing the recent new partnership with the University of Edinburgh will build on our existing track record of sourcing and shaping exciting investment prospects. "There is tremendous potential within the portfolio which Mercia is nurturing to build shareholder value. I look forward to providing future updates where we will detail the continued and positive progress of our sector portfolio."
aishah
07/11/2017
09:59
5 Bullish signals on 6 Nov 2017 (33.63) Price Crosses Moving Average (21-day) Relative Strength Index (RSI) Moving Average Convergence/Divergence (MACD) Momentum Williams %R
turbocharge
06/11/2017
21:51
Thinking of investing here,does anyone have links to any broker notes.Thanks.
baggariddim
06/11/2017
16:35
A new BUY recommendation in Techinvest. Excellent write-up.
aishah
Chat Pages: 9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180223 14:58:04